About Phythea
Phythea was founded in 2002 and is headquartered in Reims, France. The company operates within the food and beverage sector, where nutritional drinks are produced for health-focused consumers. Manufacturing processes are handled at facilities in France, with product details and online access available through the domain phythea.com. Distribution occurs primarily in European markets, emphasizing standard nutritional formulations.
- Headquarter Reims, France
- SectorsHealthcare
- Website phythea.com
- Acquired by Noreva (Feb 2016)
Investors in Phythea
Phythea has secured backing from 1 investor. Prominent investors backing the company include Noreva.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Noreva is recognized as a dermatological skincare brand. | – | noreva-laboratoires.com | France |
Investor details for Phythea
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Phythea
2 dated milestones of Phythea across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Phythea is founded.
- Exit Acquired by Noreva.
Similar companies to Phythea
10 companies that operate in the same segment as Phythea (Traditional Health & Nutrition), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | – | USD 3.02 B | 8,300 | |
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | – | USD 5.1 B | 13,500 | |
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals. | 1901 | Petah Tikva, Central District, Israel | USD 500 M | USD 18.74 B | 51,792 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | – | USD 508.93 M | 5,180 | |
Pharmaceutical products are developed and marketed globally. | 2009 | Montville, New Jersey, United States | USD 155.92 M | – | – | |
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | – | USD 6.21 B | 25,870 | |
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations | 1991 | Delhi, Delhi, India | USD 367.2 M | USD 1.52 B | 21,320 | |
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt. | 1967 | Mumbai, Maharashtra, India | – | USD 353.53 M | 3,410 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Phythea
Phythea was founded in 2002.
Phythea is headquartered in Reims, France. It is registered at Reims, Grand Est, France.
Phythea was founded in 2002 and is headquartered in Reims, France. The company operates within the food and beverage sector, where nutritional drinks are produced for health-focused consumers. Manufacturing processes are handled at facilities in France, with product details and online access available through the domain phythea.com. Distribution occurs primarily in European markets, emphasizing standard nutritional formulations.
Phythea has 1 investor. Key investors include Noreva.
Yes. Phythea was acquired by Noreva in February 2016.